Quick Overview: Breast Cancer is one of the most common cancers for women in the united states. When it comes to metastatic breast cancer, ... Beacon is uh a very important uh trial in the setting of refractory Developments in breast cancer treatment technology for

Dr Edith Perez On Her - Detailed Overview & Context

Breast Cancer is one of the most common cancers for women in the united states. When it comes to metastatic breast cancer, ... Beacon is uh a very important uh trial in the setting of refractory Developments in breast cancer treatment technology for I'm a VPN head of by oncology us medical affairs for genentech and I'm also a

Photo Gallery

Dr. Edith Perez on her Anticipated Results for ASCO and SABCS
Meet Dr. Edith Perez | Minority Health Month | Stand Up To Cancer
Dr. Edith Perez on Adjuvant Treatments
Dr. Edith Perez | Daily Flash
Dr. Edith Perez Discusses Her Ongoing Research
Dr. Edith Perez Discusses BOLERO-1 Trial Results for HER2-Positive Breast Cancer
Dr. Edith Perez on the Etirinotecan Pegol for HER2-Negative Breast Cancer
Herceptin trial for breast cancer
Dr. Edith Perez Discusses Adjuvant Chemotherapy Patient Selection
Dr. Edith Perez Discusses Anti-HER2 Therapies -- 2012 SABCS
Edith A. Perez, MD:  Anti-HER2 Therapies
Conquering Cancer  Personalized Medicine Is the Future  \\  Edith Perez
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored